Literature DB >> 29067428

Effect of Therapeutic Hypothermia Initiated After 6 Hours of Age on Death or Disability Among Newborns With Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial.

Abbot R Laptook1, Seetha Shankaran2, Jon E Tyson3, Breda Munoz4, Edward F Bell5, Ronald N Goldberg6, Nehal A Parikh7, Namasivayam Ambalavanan8, Claudia Pedroza3, Athina Pappas2, Abhik Das9, Aasma S Chaudhary10, Richard A Ehrenkranz11, Angelita M Hensman1, Krisa P Van Meurs12,13, Lina F Chalak14, Amir M Khan3, Shannon E G Hamrick15, Gregory M Sokol16, Michele C Walsh17, Brenda B Poindexter7,16, Roger G Faix18, Kristi L Watterberg19, Ivan D Frantz20, Ronnie Guillet21, Uday Devaskar22, William E Truog23,24, Valerie Y Chock12,13, Myra H Wyckoff14, Elisabeth C McGowan1, David P Carlton15, Heidi M Harmon16, Jane E Brumbaugh5, C Michael Cotten6, Pablo J Sánchez25, Anna Maria Hibbs17, Rosemary D Higgins26.   

Abstract

Importance: Hypothermia initiated at less than 6 hours after birth reduces death or disability for infants with hypoxic-ischemic encephalopathy at 36 weeks' or later gestation. To our knowledge, hypothermia trials have not been performed in infants presenting after 6 hours. Objective: To estimate the probability that hypothermia initiated at 6 to 24 hours after birth reduces the risk of death or disability at 18 months among infants with hypoxic-ischemic encephalopathy. Design, Setting, and Participants: A randomized clinical trial was conducted between April 2008 and June 2016 among infants at 36 weeks' or later gestation with moderate or severe hypoxic-ischemic encephalopathy enrolled at 6 to 24 hours after birth. Twenty-one US Neonatal Research Network centers participated. Bayesian analyses were prespecified given the anticipated limited sample size. Interventions: Targeted esophageal temperature was used in 168 infants. Eighty-three hypothermic infants were maintained at 33.5°C (acceptable range, 33°C-34°C) for 96 hours and then rewarmed. Eighty-five noncooled infants were maintained at 37.0°C (acceptable range, 36.5°C-37.3°C). Main Outcomes and Measures: The composite of death or disability (moderate or severe) at 18 to 22 months adjusted for level of encephalopathy and age at randomization.
Results: Hypothermic and noncooled infants were term (mean [SD], 39 [2] and 39 [1] weeks' gestation, respectively), and 47 of 83 (57%) and 55 of 85 (65%) were male, respectively. Both groups were acidemic at birth, predominantly transferred to the treating center with moderate encephalopathy, and were randomized at a mean (SD) of 16 (5) and 15 (5) hours for hypothermic and noncooled groups, respectively. The primary outcome occurred in 19 of 78 hypothermic infants (24.4%) and 22 of 79 noncooled infants (27.9%) (absolute difference, 3.5%; 95% CI, -1% to 17%). Bayesian analysis using a neutral prior indicated a 76% posterior probability of reduced death or disability with hypothermia relative to the noncooled group (adjusted posterior risk ratio, 0.86; 95% credible interval, 0.58-1.29). The probability that death or disability in cooled infants was at least 1%, 2%, or 3% less than noncooled infants was 71%, 64%, and 56%, respectively. Conclusions and Relevance: Among term infants with hypoxic-ischemic encephalopathy, hypothermia initiated at 6 to 24 hours after birth compared with noncooling resulted in a 76% probability of any reduction in death or disability, and a 64% probability of at least 2% less death or disability at 18 to 22 months. Hypothermia initiated at 6 to 24 hours after birth may have benefit but there is uncertainty in its effectiveness. Trial Registration: clinicaltrials.gov Identifier: NCT00614744.

Entities:  

Mesh:

Year:  2017        PMID: 29067428      PMCID: PMC5783566          DOI: 10.1001/jama.2017.14972

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  37 in total

Review 1.  Methods in health service research. An introduction to bayesian methods in health technology assessment.

Authors:  D J Spiegelhalter; J P Myles; D R Jones; K R Abrams
Journal:  BMJ       Date:  1999-08-21

2.  Performance of informative priors skeptical of large treatment effects in clinical trials: A simulation study.

Authors:  Claudia Pedroza; Weilu Han; Van Thi Thanh Truong; Charles Green; Jon E Tyson
Journal:  Stat Methods Med Res       Date:  2015-12-13       Impact factor: 3.021

3.  Why animal studies are often poor predictors of human reactions to exposure.

Authors:  Michael B Bracken
Journal:  J R Soc Med       Date:  2009-03       Impact factor: 5.344

4.  Development and reliability of a system to classify gross motor function in children with cerebral palsy.

Authors:  R Palisano; P Rosenbaum; S Walter; D Russell; E Wood; B Galuppi
Journal:  Dev Med Child Neurol       Date:  1997-04       Impact factor: 5.449

5.  Clinical trials and rare diseases: a way out of a conundrum.

Authors:  R J Lilford; J G Thornton; D Braunholtz
Journal:  BMJ       Date:  1995-12-16

6.  Elevated temperature after hypoxic-ischemic encephalopathy: risk factor for adverse outcomes.

Authors:  Abbot Laptook; Jon Tyson; Seetha Shankaran; Scott McDonald; Richard Ehrenkranz; Avroy Fanaroff; Edward Donovan; Ronald Goldberg; T Michael O'Shea; Rosemary D Higgins; W Kenneth Poole
Journal:  Pediatrics       Date:  2008-09       Impact factor: 7.124

7.  Elevated temperature and 6- to 7-year outcome of neonatal encephalopathy.

Authors:  Abbot R Laptook; Scott A McDonald; Seetha Shankaran; Bonnie E Stephens; Betty R Vohr; Ronnie Guillet; Rosemary D Higgins; Abhik Das
Journal:  Ann Neurol       Date:  2013-04-17       Impact factor: 10.422

8.  Moderate hypothermia mitigates neuronal damage in the rat brain when initiated several hours following transient cerebral ischemia.

Authors:  C Coimbra; T Wieloch
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

9.  A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy.

Authors:  Dwight J Rouse; Deborah G Hirtz; Elizabeth Thom; Michael W Varner; Catherine Y Spong; Brian M Mercer; Jay D Iams; Ronald J Wapner; Yoram Sorokin; James M Alexander; Margaret Harper; John M Thorp; Susan M Ramin; Fergal D Malone; Marshall Carpenter; Menachem Miodovnik; Atef Moawad; Mary J O'Sullivan; Alan M Peaceman; Gary D V Hankins; Oded Langer; Steve N Caritis; James M Roberts
Journal:  N Engl J Med       Date:  2008-08-28       Impact factor: 91.245

10.  Effect of Depth and Duration of Cooling on Death or Disability at Age 18 Months Among Neonates With Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial.

Authors:  Seetha Shankaran; Abbot R Laptook; Athina Pappas; Scott A McDonald; Abhik Das; Jon E Tyson; Brenda B Poindexter; Kurt Schibler; Edward F Bell; Roy J Heyne; Claudia Pedroza; Rebecca Bara; Krisa P Van Meurs; Carolyn M Petrie Huitema; Cathy Grisby; Uday Devaskar; Richard A Ehrenkranz; Heidi M Harmon; Lina F Chalak; Sara B DeMauro; Meena Garg; Michelle E Hartley-McAndrew; Amir M Khan; Michele C Walsh; Namasivayam Ambalavanan; Jane E Brumbaugh; Kristi L Watterberg; Edward G Shepherd; Shannon E G Hamrick; John Barks; C Michael Cotten; Howard W Kilbride; Rosemary D Higgins
Journal:  JAMA       Date:  2017-07-04       Impact factor: 56.272

View more
  64 in total

Review 1.  The present and future of cardiac arrest care: international experts reach out to caregivers and healthcare authorities.

Authors:  Jerry P Nolan; Robert A Berg; Clifton W Callaway; Laurie J Morrison; Vinay Nadkarni; Gavin D Perkins; Claudio Sandroni; Markus B Skrifvars; Jasmeet Soar; Kjetil Sunde; Alain Cariou
Journal:  Intensive Care Med       Date:  2018-06-02       Impact factor: 17.440

Review 2.  Emerging therapies and management for neonatal encephalopathy-controversies and current approaches.

Authors:  Ryan M McAdams; Megan W Berube
Journal:  J Perinatol       Date:  2021-03-12       Impact factor: 2.521

Review 3.  Therapeutic Hypothermia in Neonatal Hypoxic-Ischemic Encephalopathy.

Authors:  Guido Wassink; Joanne O Davidson; Simerdeep K Dhillon; Kelly Zhou; Laura Bennet; Marianne Thoresen; Alistair J Gunn
Journal:  Curr Neurol Neurosci Rep       Date:  2019-01-14       Impact factor: 5.081

4.  Photobiomodulation preconditioning prevents cognitive impairment in a neonatal rat model of hypoxia-ischemia.

Authors:  Luodan Yang; Yan Dong; Chongyun Wu; Yong Li; Yichen Guo; Baocheng Yang; Xuemei Zong; Michael R Hamblin; Timon C-Y Liu; Quanguang Zhang
Journal:  J Biophotonics       Date:  2019-02-14       Impact factor: 3.207

5.  Bayesian clinical trials at The University of Texas MD Anderson Cancer Center: An update.

Authors:  Rebecca S Slack Tidwell; S Andrew Peng; Minxing Chen; Diane D Liu; Ying Yuan; J Jack Lee
Journal:  Clin Trials       Date:  2019-08-26       Impact factor: 2.486

6.  Does late therapeutic hypothermia reduce risk of death or disability?

Authors:  Stephanie L Bourque; Robert M Dietz
Journal:  Acta Paediatr       Date:  2018-04-19       Impact factor: 2.299

Review 7.  Neuroprotection Strategies for Term Encephalopathy.

Authors:  Fernando F Gonzalez
Journal:  Semin Pediatr Neurol       Date:  2019-08-07       Impact factor: 1.636

8.  Proactive delivery of nicotine replacement therapy to families of hospitalized infants in a NICU: A randomized controlled pilot trial.

Authors:  Thomas F Northrup; Robert Suchting; Michelle R Klawans; Amir M Khan; Yolanda R Villarreal; Charles Green; Angela L Stotts
Journal:  J Neonatal Nurs       Date:  2020-01-11

9.  An In Vivo Assessment of Regional Brain Temperature during Whole-Body Cooling for Neonatal Encephalopathy.

Authors:  Tai-Wei Wu; Jessica L Wisnowski; Robert F Geisler; Aaron Reitman; Eugenia Ho; Benita Tamrazi; Rachel Chapman; Stefan Blüml
Journal:  J Pediatr       Date:  2020-02-20       Impact factor: 4.406

10.  Non-invasive optical neuromonitoring of the temperature-dependence of cerebral oxygen metabolism during deep hypothermic cardiopulmonary bypass in neonatal swine.

Authors:  Tiffany S Ko; Constantine D Mavroudis; Wesley B Baker; Vincent C Morano; Kobina Mensah-Brown; Timothy W Boorady; Alexander L Schmidt; Jennifer M Lynch; David R Busch; Javier Gentile; George Bratinov; Yuxi Lin; Sejin Jeong; Richard W Melchior; Tami M Rosenthal; Brandon C Shade; Kellie L Schiavo; Rui Xiao; J William Gaynor; Arjun G Yodh; Todd J Kilbaugh; Daniel J Licht
Journal:  J Cereb Blood Flow Metab       Date:  2018-10-30       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.